Loading...
United States · effective Apr 9, 2025
Scope details are not available in the current dossier.
Quote: "A bill aimed at improving health outcomes for Medicare patients by encouraging the use of cutting-edge, AI-enabled medical devices. The bill will assign all US Food and Drug Administration (FDA) approved AI-enabled medical devices to a New Technology Ambulatory Payment Classification (APC) in the Hospital Outpatient Prospective Payment System (OPPS) a minimum of 5 years so that adequate data regarding delivery and service costs is acquired before assignment of a permanent payment code. Specifically, the bill would: (1) develop a formalized payment pathway for ABHS FDA-cleared medical devices; (2) provide patients with access to innovative, AI-enabled clinical technology; (3) provide manufacturers and providers with the certainty they need to invest in developing next-generation healthcare technologies and bringing them to market, and (4) improve patient outcomes, providing resources for providers to meet ABHS standards of care."
Same act in other jurisdictions